Researchers seeking an off-the-shelf solution for screening of activity against human Peroxisome proliferator-activated receptor alpha and delta (also known as beta) as well as Liver X receptor alpha, members of the family of human Nuclear Receptors, now have assay systems that are ready to use when you’re ready to test. INDIGO Biosciences introduces the human PPARa, PPARd, and LXRa Assay Systems, the newest additions to our expanding portfolio of cell-based, nuclear receptor reporter assay products for on-demand use in drug discovery and development. INDIGO Biosciences’ assays enable sensitive screening of test compounds for agonist or antagonist activities for use in primary screening or secondary and toxicology screening. The all-inclusive assay systems feature high signal-to-noise ratios, and excellent Z’ scores. The Company’s proprietary cryopreservation process, CryoMite, permits overnight delivery for on-demand use. Kits are optimally configured for HTS or low throughput screening in 3x 32-, 96- and 384-well plate formats.

INDIGO Biosciences, 814-234-1919, www.indigobiosciences.com